Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

n-3 fatty acids for prevention of restenosis

July 11, 1997

Magnesium implicated in death from cardiovascular disease

July 11, 1997

TEI-A0225: new treatment for restenosis

July 11, 1997

Cardiovascular effects of psychotropic drugs

July 11, 1997

Chugai reports sydnonimine derivatives for angina

July 11, 1997

CPC-111 moves toward pivotal trials for bypass surgery

July 10, 1997

Yamanouchi, Ferring collaborate on endothelin antagonists

July 10, 1997

New lactam compounds for sepsis and RA

July 10, 1997

Low-dose combination of ramipril and felodipine evaluated in SHR

July 9, 1997

Fixed-dose losartan/hydrochlorothiazide combination now available in U.K.

July 8, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
EQ-504 is AhR agonist for ulcerative colitis, related disorders
BioWorld Science
Activating the aryl hydrocarbon receptor (AhR) in immune cells enhances anti-inflammatory pathways and limits pathogenic immune responses. Equillium Inc. has...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...